LinCor Biosciences, Pte. Ltd., a Singapore-based developer and manufacturer of bioengineered corneas, raised $500k in funding.
The Indiana Lions Eye Bank, Indianapolis, IN, USA, made the investment.
The company intends to use the funds to accelerate final pre-market activities.
Led by Dr. James Socks, CEO, LinCor is advancing bioengineered corneas, which have shown complete biocompatibility in extensive clinical studies in animals and in a long term human clinical trial.
The company aims to help reduce the shortage of donor corneas in most countries around the world.